FDA Inspection 1218067 - Samsung Biologics Co., Ltd. - September 01, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Samsung Biologics Co., Ltd., with an inspection on September 1, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Samsung Biologics Co., Ltd.
Inspection Date: September 1, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 4f09b686-db97-4bd1-85fb-2ebcd9a54f72